Prerequisites for the creation of an atlas of postcovid inflammation as a way of personalized pharmacotherapy, as well as predicting and preventing organ and systemic dysfunctions

SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 continue to grow, it’s very important to understand wh...

ver descrição completa

Detalhes bibliográficos

Principais autores:	I. V. Kukes, J. M. Salmasi, K. S. Ternovoy, A. N. Kazimirskii, T. E. Obodzinskaya, V. G. Lim, P. B. Glagovskiy, I. S. Mamedov, G. V. Poryadin, A. S. Savicheva, E. A. Kukes, M. S. Ptitsyn, A. D. Andreev
Formato:	Artigo
Idioma:	Russo
Publicado em:	Remedium Group LLC 2021-09-01
coleção:	Медицинский совет
Assuntos:	post-covid-19 syndrome personalized pharmacotherapy covid-19 metabolic disorders neurological disorders
Acesso em linha:	https://www.med-sovet.pro/jour/article/view/6334
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!